Lipid Composition Features in Elderly Patients with Ischemic Heart Disease and Chronic Kidney Disease

Мirkhayotov M.M; Daminov B.T.

Authors

Мirkhayotov M.M Tashkent Pediatric Medical Institute
Daminov B.T. Tashkent Pediatric Medical Institute

Keywords:

ischemic heart disease (IHD), chronic kidney disease (CKD), blood lipids

Abstract

As chronic kidney disease (CKD) progresses and the glomerular filtration rate (GFR) declines, lipid metabolism parameters deteriorate: levels of low-density lipoproteins (LDL), triglycerides, and the atherogenic index increase, while high-density lipoprotein (HDL) levels decrease. These changes emphasize the need for lipid profile monitoring in CKD patients, as dyslipidemia is a significant risk factor for cardiovascular complications. CKD treatment should include the correction of lipid metabolism disorders, particularly in patients with low GFR, to reduce the risk of atherosclerotic complications.

Downloads

Download data is not yet available.

References

1 Ronco C, McCullough P, Anker S. et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 2010; 31:703-711.

2 Matsushita K, van der Velde M, Astor BC et al, Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375(9731):2073-81.

3 Whaley-Connell AT, Vassalotti JA, Collins AJ et al. National Kidney Foundation’s Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary. Am J Kidney Dis. 2012;59(3)(suppl 2):S1-S4.

4 Bakris GL, Seraﬁdis PA, Weir MR et al. ACCOMPLISH Trial Investigators. Renal outcomes with different ﬁxed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespeciﬁed secondary analysis of randomised controlled trial. Lancet 2010;375: 1173-1181.